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Nanopore sequencing is a recent technology that allows direct real-time sequencing of DNA/RNA 
molecules with read lengths as long as the size of the original fragments. The characteristics of 
nanopore sequencing make it well suited for whole genome sequencing and as a preferential tool 
to identify structural variants (SV), namely those associated with tumours. In this work, we present 
a complete workflow to detect SV in tumour samples using nanopore sequencing. We used a tumour 
sample to prepare DNA libraries using the Rapid Sequencing kit (Oxford Nanopore Technologies-
ONT), sequenced those on the MinION device (ONT) and implemented a pipeline for SV detection 
using multiple bioinformatics tools. The MinION generated a total of 2.34 Gb of sequence. Overall, 
87.8% of reads had a quality (Q) value >7 (quality threshold). The longest read obtained had 74369 
bases and the mean read length was of 4508 bases. A total of 3470 SV were identified, including 
deletions, duplications, translocations, insertions and inversions. Nanopore sequencing is a fast and 
sensitive approach of great potential for human genomics research, namely in the detection of SV 
in the human genome. (This work was supported by Centre for Toxicogenomics and Human Health 
- UID/BIM/00009/2019 - and GenomePT project – POCI-01-0145-FEDER-022184) 
 
 
